
Stephen L. Rawlings
Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1642, 1643, 1646 |
| Total Applications | 1483 |
| Issued Applications | 633 |
| Pending Applications | 153 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7297229
[patent_doc_number] => 20040214779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'MAGE-C2 antigenic peptides and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/670472
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19777
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10670472
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/670472 | MAGE-C2 antigenic peptides and uses thereof | Sep 25, 2003 | Issued |
Array
(
[id] => 5597073
[patent_doc_number] => 20060160991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Genes and polypeptides relating to prostate cancers'
[patent_app_type] => utility
[patent_app_number] => 10/529381
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22864
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529381 | Genes and polypeptides relating to prostate cancers | Sep 21, 2003 | Issued |
Array
(
[id] => 7286956
[patent_doc_number] => 20040146954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Compositions that specifically bind to colorectal cancer cells and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 10/656895
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 34428
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10656895
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/656895 | Compositions that specifically bind to colorectal cancer cells and methods of using the same | Sep 4, 2003 | Issued |
Array
(
[id] => 7083122
[patent_doc_number] => 20050048502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Human SACH-related gene variants associated with cancers'
[patent_app_type] => utility
[patent_app_number] => 10/653680
[patent_app_country] => US
[patent_app_date] => 2003-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 6115
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10653680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/653680 | Human SACH-related gene variants associated with cancers | Sep 1, 2003 | Abandoned |
Array
(
[id] => 5613889
[patent_doc_number] => 20060115817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Span-xb gene and protein for the diagnosis and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/525623
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8140
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525623
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525623 | Span-xb gene and protein for the diagnosis and treatment of cancer | Aug 28, 2003 | Abandoned |
Array
(
[id] => 7290875
[patent_doc_number] => 20040110712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Methods for treating patients and identifying therapeutics'
[patent_app_type] => new
[patent_app_number] => 10/650112
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 29270
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10650112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/650112 | Methods for treating patients and identifying therapeutics | Aug 25, 2003 | Abandoned |
Array
(
[id] => 5800084
[patent_doc_number] => 20060035237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Methods and compositions for categorizing patients'
[patent_app_type] => utility
[patent_app_number] => 10/649591
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 21349
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10649591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/649591 | Methods and compositions for categorizing patients | Aug 25, 2003 | Abandoned |
Array
(
[id] => 382974
[patent_doc_number] => 07306926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Method for detecting carcinomas in a solubilized cervical body sample'
[patent_app_type] => utility
[patent_app_number] => 10/650057
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9203
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/306/07306926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10650057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/650057 | Method for detecting carcinomas in a solubilized cervical body sample | Aug 25, 2003 | Issued |
Array
(
[id] => 7382448
[patent_doc_number] => 20040029195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Compositions and methods for cancer screening'
[patent_app_type] => new
[patent_app_number] => 10/333543
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5378
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333543 | Compositions and methods for cancer screening | Aug 24, 2003 | Abandoned |
Array
(
[id] => 6971300
[patent_doc_number] => 20050037010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer'
[patent_app_type] => utility
[patent_app_number] => 10/645756
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 41542
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10645756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/645756 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | Aug 19, 2003 | Issued |
Array
(
[id] => 7434106
[patent_doc_number] => 20040266679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/635535
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 20355
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266679.pdf
[firstpage_image] =>[orig_patent_app_number] => 10635535
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/635535 | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | Aug 6, 2003 | Abandoned |
Array
(
[id] => 322430
[patent_doc_number] => 07517662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Method for solution based diagnosis'
[patent_app_type] => utility
[patent_app_number] => 10/633484
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16517
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517662.pdf
[firstpage_image] =>[orig_patent_app_number] => 10633484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/633484 | Method for solution based diagnosis | Jul 30, 2003 | Issued |
Array
(
[id] => 5894776
[patent_doc_number] => 20060003315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes'
[patent_app_type] => utility
[patent_app_number] => 10/517784
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17183
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003315.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517784 | Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes | Jun 11, 2003 | Abandoned |
Array
(
[id] => 4903930
[patent_doc_number] => 20080113343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Method of Inhibiting Prostate Cancer Cell Proliferation'
[patent_app_type] => utility
[patent_app_number] => 10/517256
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10098
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517256 | Method of inhibiting prostate cancer cell proliferation | Jun 9, 2003 | Issued |
Array
(
[id] => 507855
[patent_doc_number] => 07198899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-03
[patent_title] => 'Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers'
[patent_app_type] => utility
[patent_app_number] => 10/454764
[patent_app_country] => US
[patent_app_date] => 2003-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14539
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/198/07198899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454764 | Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers | Jun 2, 2003 | Issued |
Array
(
[id] => 553633
[patent_doc_number] => 07157087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Enhancement of intracellular delivery and tissue targeting of drugs and genes'
[patent_app_type] => utility
[patent_app_number] => 10/446422
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7371
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10446422
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/446422 | Enhancement of intracellular delivery and tissue targeting of drugs and genes | May 27, 2003 | Issued |
Array
(
[id] => 7288634
[patent_doc_number] => 20040109856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Slit1 and MEGF4 isoforms and their use'
[patent_app_type] => new
[patent_app_number] => 10/442658
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5827
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20040109856.pdf
[firstpage_image] =>[orig_patent_app_number] => 10442658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/442658 | Slit1 and MEGF4 isoforms and their use | May 20, 2003 | Abandoned |
Array
(
[id] => 7069443
[patent_doc_number] => 20050244828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma'
[patent_app_type] => utility
[patent_app_number] => 10/514910
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12798
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244828.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514910 | Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma | May 19, 2003 | Abandoned |
Array
(
[id] => 5807199
[patent_doc_number] => 20060093553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Cd26-based therapies for cancers and immune disease'
[patent_app_type] => utility
[patent_app_number] => 10/514738
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 46982
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514738 | Cd26-based therapies for cancers and immune disease | May 14, 2003 | Abandoned |
Array
(
[id] => 7378972
[patent_doc_number] => 20040028685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'EphA2 monoclonal antibodies and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/436782
[patent_app_country] => US
[patent_app_date] => 2003-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 46871
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20040028685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10436782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/436782 | EphA2 monoclonal antibodies and methods of use thereof | May 11, 2003 | Abandoned |